Argonne maintains a wide-ranging science and technology portfolio that seeks to address complex challenges in interdisciplinary and innovative ways. Below is a list of all articles, highlights, profiles, projects, and organizations related specifically to molecular biology.
Clinical trials have begun on a new vaccine candidate that may protect against variants of the SARS-CoV-2 virus. Protein structures determined at the Advanced Photon Source helped to guide the development of this vaccine.
Research teams from across the United States are making use of the Advanced Photon Source’s remote access capabilities to better understand the virus that causes COVID-19, and to move forward on treatments and vaccines to combat it.